10/16/19 |
NIH |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2018, 2019, and 2020 (P50 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
12/07/18 |
NIH |
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/28/20 |
NIH |
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed) |
Link |
NIH |
Standard due dates apply |
04/03/20 |
NIH |
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) |
Link |
NIH |
Due dates may vary by awarding IC. See Table of IC-Specific Information, Requi… |
02/27/20 |
NIH |
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
03/06/19 |
NIH |
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
05/31/18 |
NIH |
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) |
Link |
NIH |
Standard dates apply |
05/06/19 |
NIH |
Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21) |
Link |
NIH |
Standard due dates apply |
07/23/20 |
NIH |
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard dates |
04/01/22 |
NIH |
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
04/17/20 |
NIH |
NIH Funding Opportunities Specific to COVID-19 (various) |
Link |
NIH COVID-19 |
See list of notices for funding opps and due dates |
03/11/24 |
NIH |
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) |
Link |
NIH |
Application due: 06/18/24 |
11/22/19 |
NIH |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NIH |
Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics |
Link |
NIH NOSI |
Application due: 12/31/24 |
07/23/20 |
NIH |
Notice of Special Interest: Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01, R21) |
Link |
NIH |
Standard due dates apply |
11/30/18 |
NIH |
Examination of Survivorship Care Planning Efficacy and Impact (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
01/11/19 |
NIH |
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) |
Link |
NIH |
Standard due dates apply |
05/22/18 |
NIH |
Metabolic Reprogramming to Improve Immunotherapy (R01) |
Link |
Research |
Standard due dates apply |
07/08/22 |
NIH |
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/17/19 |
NIH |
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
Link |
NIH |
|
11/22/19 |
NIH |
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
09/19/19 |
NIH |
Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed) |
Link |
NIH |
|
11/30/18 |
NIH |
Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
01/24/23 |
NIH |
Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research |
Link |
NIH NOSI |
Application due: 12/31/24 |
11/08/20 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) |
Link |
NIH |
Standard due dates apply |
02/14/20 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
Link |
NIH |
Standard due dates apply |
02/14/20 |
NIH |
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
04/02/21 |
NIH |
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
04/18/19 |
NIH |
Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R01) |
Link |
NIH |
Standard due dates apply |
07/20/18 |
NIH |
Postbac IRTA program (CRTA, Cancer Research Training Award, in the National Cancer Institute) |
Link |
Fellowship |
|
03/04/22 |
NIH |
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
06/10/20 |
NIH |
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply - Note new SBIR/STTR Standard Due Dates. |
11/02/18 |
NIH |
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) |
Link |
NIH |
Standard dates apply |
11/21/18 |
NIH |
Metabolic Reprogramming to Improve Immunotherapy (R21) |
Link |
NIH |
Standard due dates apply |
10/22/20 |
NIH |
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
Link |
NIH |
Due dates may vary by awarding IC. See the awarding IC's web site or applicabl… |
10/04/23 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) |
Link |
NIH |
Standard due dates apply |
07/18/18 |
NIH |
Gene Fusions in Pediatric Sarcomas (R21) |
Link |
NIH |
Standard dates apply |
01/17/24 |
NIH |
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/27/19 |
NIH |
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) |
Link |
NIH |
Standard dates apply |
10/07/22 |
NIH |
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments |
Link |
NOSI |
|
05/22/20 |
NIH |
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/13/20 |
NIH |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/21/18 |
NIH |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/09/20 |
NIH |
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
Link |
NIH |
A successor-in-interest request must be made before the anticipated start date … |
12/06/19 |
NIH |
Co-infection and Cancer (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
12/17/19 |
NIH |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/04/21 |
NIH |
Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease |
Link |
NIH |
Application due: 05/07/24 |
07/10/20 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) |
Link |
NIH |
Standard due dates apply |
01/21/22 |
NIH |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
05/25/19 |
NIH |
The Role of Mobile Genetic Elements in Cancer (R01) |
Link |
NIH |
Standard due dates apply |
10/19/18 |
NIH |
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21) |
Link |
NIH |
Standard AIDS dates apply |
10/07/22 |
NIH |
Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy |
Link |
NOSI |
|
05/15/20 |
NIH |
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/23/20 |
NIH |
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/21/18 |
NIH |
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/05/20 |
NIH |
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/08/19 |
NIH |
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/07/18 |
NIH |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
04/17/20 |
NIH |
Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars |
Link |
NIH |
Application due: 10/01/25 |
01/25/19 |
NIH |
Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/29/23 |
NIH |
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
03/18/21 |
NIH |
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/14/21 |
NIH |
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research |
Link |
NIH NOSI |
Application due: 01/08/25 |
05/25/19 |
NIH |
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21) |
Link |
NIH |
Standard due dates apply |
08/19/21 |
NIH |
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) |
Link |
NIH |
Standard dates apply |
04/08/22 |
NIH |
Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging |
Link |
NIH NOSI |
Application due: 05/08/24 |
04/30/20 |
NIH |
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
Link |
NIH |
Due dates vary by awarding IC |
08/08/19 |
NIH |
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01) |
Link |
NIH |
Standard due dates apply |
11/22/19 |
NIH |
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
09/22/22 |
NIH |
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech |
Link |
NOSI |
|
07/23/20 |
NIH |
PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
10/30/19 |
NIH |
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/07/18 |
NIH |
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/28/20 |
NIH |
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
Link |
NIH |
Submission dates vary by awarding IC |
04/10/20 |
NIH |
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
02/14/20 |
NIH |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
05/14/21 |
NIH |
Notice of Special Interest: Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and Outcomes |
Link |
NIH |
Application due: 09/08/24 |
09/07/18 |
NIH |
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
Link |
NIH |
Due dates vary by awarding IC. |